
    
      PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive
      intravenous acetylcysteine or placebo for 72 hours. Treatment must begin within 12 hours of
      hospitalization. Patients who advance to grade III or IV encephalopathy are eligible for
      liver transplantation.

      Patients are followed at 3 weeks.
    
  